Becton, Dickinson (BDX) and Fujirebio Diagnostics Sign Worldwide Agreement to Develop Biomarker Assays to Improve Cancer Detection
Tweet Send to a Friend
BD (Becton, Dickinson and Company) (NYSE: BDX) and Fujirebio Diagnostics, Inc., announced the signing of a worldwide development and supply ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
